The Coming Era of Quadrivalent Human Influenza Vaccines: Who will Benefit?

Author： Barr Ian G.   Jelley Lauren L.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.72, Iss.17, 2012-12, pp. : 2177-2185

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging vaccines for influenza

By Tosh Pritish K   Poland Gregory A  

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 1, 2008-03 ,pp. : 21-40

Informa Healthcare

Access to resources Recommend Favorite

More is better for influenza vaccines

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 667, 2012-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Bivalent vs quadrivalent HPV vaccines: which is best?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 639, 2011-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Safety and Immunogenicity of Conventional Subunit and MF59-adjuvanted Influenza Vaccines in Human Immunodeficiency Virus-1-seropositive Patients

By Gabutti G   Guido M   Durando P   de Donno A   Quattrocchi M   Bacilieri S   Ansaldi F   Cataldini S   Chiriacò PG   de Simone M   Minniti S   Sticchi L   Gasparini R  

The Journal of International Medical Research, Vol. 33, Iss. 4, 2005-07 ,pp. : 406-416

Field House Publishing

Access to resources Recommend Favorite

Influenza vaccines: Bronchitis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1247-1248, 2009-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite